CCOI:NASDAQCogent Communications Holdings, Inc. Analysis
Data as of 2026-06-01 - not real-time
$17.76
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Cogent Communications (CCOI) is trading at $17.76, well below its 52‑week high of $54.37 and near the computed support level of $14.82. The stock sits under its 20‑day SMA ($17.82) and 50‑day SMA ($19.76), with a bearish trend direction and a decreasing volume trend, while the MACD histogram is modestly positive but the MACD line remains below the signal line, suggesting limited short‑term upside. Fundamentals are weak: revenue fell 3.2% YoY to $239.2 M, GAAP EPS was a loss of $0.83, operating margin is negative (-7.5%), and both operating and free cash flow are negative. The company also faces a legal investigation into potential securities claims, adding further headwinds. Valuation metrics are distorted – PE and PB are negative, price‑to‑sales is near parity (≈1), and the dividend yield is high at 6.05% but the payout ratio exceeds 500%, making the dividend unsustainable. Analysts on average project a price target of $21.27, implying roughly 20% upside, yet the high beta (1.65) and extreme 30‑day volatility (126%) amplify risk.
Given the bearish technical setup, deteriorating earnings, mounting legal risk, and an unsustainable dividend, the stock appears fairly priced at best and may be slightly undervalued relative to its recent lows, but the upside is constrained by fundamental weaknesses. The high overall risk score (8/10) and medium‑to‑high sector and liquidity risks suggest caution, positioning the stock for a short‑term sell, a medium‑term hold, and a long‑term hold pending a clear turnaround.
Given the bearish technical setup, deteriorating earnings, mounting legal risk, and an unsustainable dividend, the stock appears fairly priced at best and may be slightly undervalued relative to its recent lows, but the upside is constrained by fundamental weaknesses. The high overall risk score (8/10) and medium‑to‑high sector and liquidity risks suggest caution, positioning the stock for a short‑term sell, a medium‑term hold, and a long‑term hold pending a clear turnaround.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Bearish technical positioning below key SMAs
- Q1 revenue miss and GAAP loss
- Ongoing securities‑law investigation
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- High dividend yield but unsustainable payout
- Elevated debt load and negative cash flow
- Potential upside to analyst price target
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Need for sustained earnings recovery
- Cost‑reduction initiatives and network positioning
- Continued exposure to high volatility and beta
Key Metrics & Analysis
Financial Health
Revenue Growth-3.20%
Profit Margin-19.08%
P/E Ratio-6.0
ROE-877.28%
ROA-1.62%
P/B Ratio-8.1
Op. Cash Flow$-32096000
Free Cash Flow$-108703000
Industry P/E17.0
Technical Analysis
TrendBearish
RSI45.0
Support$14.82
Resistance$24.23
MA 20$17.82
MA 50$19.76
MA 200$26.64
MACDBullish
VolumeDecreasing
Fear & Greed Index93.14
Valuation
Target Price$21.27
Upside/Downside19.78%
GradeFair
TypeValue
Dividend Yield6.05%
Risk Assessment
Beta1.65
Volatility126.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.